Action LNTH LANTHEUS HOLDINGS, INC.
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Communiqués Lantheus Holdings, Inc.

Actions

LNTH

US5165441032

Marché Fermé - Nasdaq
Autres places de cotation
 22:00:00 07/06/2024 		Varia. 5j. Varia. 1 janv.
79,9 USD -2,16 % Graphique intraday de Lantheus Holdings, Inc. -2,36 % +28,87 %
03/06 Lantheus ? aPROMISE basé sur l'IA est désormais disponible sur la plateforme syngo.via de Siemens Healthineers CI
31/05 Un initié de Lantheus Holdings a vendu des actions pour une valeur de 1 454 989 $, selon un récent dépôt auprès de la SEC MT

Communiqués

Recherche
Voir les résultats
Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !
Inscription 100% Gratuite
Lantheus’ AI-Enabled aPROMISE Now Available on Siemens Healthineers’ syngo.via platform
GL
Lantheus to Present at the William Blair 44th Annual Growth Stock Conference
GL
Lantheus to Present at the William Blair 44th Annual Growth Stock Conference
AQ
Lantheus Announces Executive Appointments to Accelerate Innovation
GL
Lantheus Holdings: Q1 Earnings Snapshot
AQ
Lantheus Reports First Quarter 2024 Financial Results
GL
Lantheus to Host First Quarter 2024 Earnings Conference Call and Webcast on May 2, 2024, at 8:00 a.m. Eastern Time
AQ
Lantheus to Host First Quarter 2024 Earnings Conference Call and Webcast on May 2, 2024, at 8:00 a.m. Eastern Time
GL
Lantheus to Present at the Leerink Partners Global Biopharma Conference 2024
GL
Lantheus Announces the FDA Approval of DEFINITY® (Perflutren Lipid Microsphere) for Pediatric Patients
GL
Lantheus Announces Promotion of Amanda Morgan to Chief Commercial Officer
GL
Lantheus Announces Promotion of Amanda Morgan to Chief Commercial Officer
AQ
Lantheus to Present at the TD Cowen 44th Annual Health Care Conference
GL
Lantheus Holdings: Q4 Earnings Snapshot
AQ
Lantheus Reports Fourth Quarter and Full Year 2023 Financial Results
GL
Lantheus Announces Collaboration to Provide Novel Tau Imaging Agent for Large Consortium Clinical Trial Sponsored by the National Institute on Aging
GL
Lantheus to Host Fourth Quarter and Full Year 2023 Earnings Conference Call and Webcast on February 22, 2024, at 8:00 a.m. Eastern Time
GL
Lantheus to Host Fourth Quarter and Full Year 2023 Earnings Conference Call and Webcast on February 22, 2024, at 8:00 a.m. Eastern Time
AQ
Lantheus Announces CEO Succession Plan
GL
Lantheus Announces CEO Succession Plan
AQ
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action LNTH
  4. Actualités Lantheus Holdings, Inc.
  5. Communiqués